Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer

BACKGROUND: Polycomb repressive complex 2 (PRC2) mediates gene silencing through histone H3K27 methylation. PRC2 components are over-expressed in metastatic prostate cancer (PC), and are required for cancer stem cell (CSC) self-renewal. 3-Dezaneplanocin-A (DZNeP) is an inhibitor of PRC2 with broad a...

Descripción completa

Detalles Bibliográficos
Autores principales: Crea, Francesco, Hurt, Elaine M, Mathews, Lesley A, Cabarcas, Stephanie M, Sun, Lei, Marquez, Victor E, Danesi, Romano, Farrar, William L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100246/
https://www.ncbi.nlm.nih.gov/pubmed/21501485
http://dx.doi.org/10.1186/1476-4598-10-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100246/
https://www.ncbi.nlm.nih.gov/pubmed/21501485
http://dx.doi.org/10.1186/1476-4598-10-40

Ejemplares similares